BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang JJ, Hong J, Ma YS, Shi Y, Zhang DD, Yang XL, Jia CY, Yin YZ, Jiang GX, Fu D, Yu F. Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression. Dis Markers 2021;2021:6696198. [PMID: 33505535 DOI: 10.1155/2021/6696198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Q, Min S, Zhou Q. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases. Biosci Rep 2021;41:BSR20204370. [PMID: 34017995 DOI: 10.1042/BSR20204370] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Zhuang Z, Zhong X, Chen Q, Chen H, Liu Z. Bioinformatics and System Biology Approach to Reveal the Interaction Network and the Therapeutic Implications for Non-Small Cell Lung Cancer Patients With COVID-19. Front Pharmacol 2022;13:857730. [PMID: 35721149 DOI: 10.3389/fphar.2022.857730] [Reference Citation Analysis]
3 Zhang DD, Wang WE, Ma YS, Shi Y, Yin J, Liu JB, Yang XL, Xin R, Fu D, Zhang WJ. A miR-212-3p/SLC6A1 Regulatory Sub-Network for the Prognosis of Hepatocellular Carcinoma. Cancer Manag Res 2021;13:5063-75. [PMID: 34234551 DOI: 10.2147/CMAR.S308986] [Reference Citation Analysis]
4 Chen JH, Wu ATH, Lawal B, Tzeng DTW, Lee JC, Ho CL, Chao TY. Identification of Cancer Hub Gene Signatures Associated with Immune-Suppressive Tumor Microenvironment and Ovatodiolide as a Potential Cancer Immunotherapeutic Agent. Cancers (Basel) 2021;13:3847. [PMID: 34359748 DOI: 10.3390/cancers13153847] [Cited by in F6Publishing: 2] [Reference Citation Analysis]